Sectoral Asset Management as of Sept. 30, 2024
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 90 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Lenz Therapeutics (LENZ) | 13.7 | $23M | 977k | 23.74 | |
Contineum Thera Cl A (CTNM) | 9.1 | $15M | 801k | 19.14 | |
Eli Lilly & Co. (LLY) | 5.8 | $9.7M | 11k | 885.94 | |
UnitedHealth (UNH) | 4.5 | $7.7M | 13k | 584.68 | |
Gilead Sciences (GILD) | 3.0 | $5.1M | 61k | 83.84 | |
Johnson & Johnson (JNJ) | 2.5 | $4.2M | 26k | 162.06 | |
Mineralys Therapeutics (MLYS) | 2.4 | $4.0M | 330k | 12.11 | |
Regeneron Pharmaceuticals (REGN) | 2.1 | $3.6M | 3.4k | 1051.24 | |
Pfizer (PFE) | 2.0 | $3.3M | 115k | 28.94 | |
Thermo Fisher Scientific (TMO) | 1.9 | $3.2M | 5.3k | 618.57 | |
Abbvie (ABBV) | 1.8 | $3.1M | 16k | 197.48 | |
Boston Scientific Corporation (BSX) | 1.6 | $2.8M | 33k | 83.80 | |
Merck & Co (MRK) | 1.6 | $2.7M | 24k | 113.56 | |
Stryker Corporation (SYK) | 1.6 | $2.7M | 7.5k | 361.26 | |
Alnylam Pharmaceuticals (ALNY) | 1.6 | $2.7M | 9.7k | 275.03 | |
Medtronic SHS (MDT) | 1.6 | $2.6M | 29k | 90.03 | |
BioMarin Pharmaceutical (BMRN) | 1.5 | $2.6M | 37k | 70.29 | |
Bristol Myers Squibb (BMY) | 1.5 | $2.6M | 50k | 51.74 | |
Astrazeneca Sp Adr (AZN) | 1.5 | $2.5M | 21k | 115.88 | |
Boundless Bio (BOLD) | 1.4 | $2.4M | 679k | 3.47 | |
Amgen (AMGN) | 1.3 | $2.3M | 7.1k | 322.21 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $2.3M | 4.8k | 465.08 | |
Abbott Laboratories (ABT) | 1.3 | $2.2M | 19k | 114.01 | |
Argenx Se Sp Adr (ARGX) | 1.3 | $2.2M | 4.0k | 542.08 | |
Iqvia Holdings (IQV) | 1.1 | $1.8M | 7.6k | 236.97 | |
Zai Lab Adr (ZLAB) | 1.0 | $1.8M | 73k | 24.14 | |
Edwards Lifesciences (EW) | 1.0 | $1.7M | 26k | 65.99 | |
Vaxcyte (PCVX) | 1.0 | $1.7M | 15k | 114.27 | |
CVS Caremark Corporation (CVS) | 0.9 | $1.6M | 26k | 62.88 | |
Biontech Se Sp Adr (BNTX) | 0.9 | $1.6M | 13k | 118.77 | |
Sarepta Therapeutics (SRPT) | 0.9 | $1.5M | 12k | 124.89 | |
Ishares Trust 0-3 Mnth Treasry (SGOV) | 0.9 | $1.5M | 15k | 100.73 | |
Cytokinetics (CYTK) | 0.9 | $1.5M | 29k | 52.80 | |
Amicus Therapeutics (FOLD) | 0.9 | $1.5M | 141k | 10.68 | |
Intuitive Surgical (ISRG) | 0.9 | $1.5M | 3.1k | 491.27 | |
Zimmer Holdings (ZBH) | 0.9 | $1.5M | 14k | 107.95 | |
Neurocrine Biosciences (NBIX) | 0.9 | $1.4M | 13k | 115.22 | |
Silverback Therapeutics (SPRY) | 0.8 | $1.4M | 99k | 14.50 | |
Blueprint Medicines (BPMC) | 0.8 | $1.4M | 15k | 92.50 | |
Moonlake Immunothera Class A Ord (MLTX) | 0.8 | $1.4M | 27k | 50.42 | |
Danaher Corporation (DHR) | 0.8 | $1.3M | 4.8k | 278.02 | |
Legend Biotech Corp Sp Adr (LEGN) | 0.8 | $1.3M | 27k | 48.73 | |
Icon SHS (ICLR) | 0.8 | $1.3M | 4.6k | 287.31 | |
Option Care Health (OPCH) | 0.7 | $1.3M | 40k | 31.30 | |
Biogen Idec (BIIB) | 0.7 | $1.2M | 6.0k | 193.84 | |
Arcus Biosciences Incorporated (RCUS) | 0.7 | $1.2M | 76k | 15.29 | |
Arvinas Ord (ARVN) | 0.7 | $1.1M | 46k | 24.63 | |
Evolent Health Cl A (EVH) | 0.7 | $1.1M | 39k | 28.28 | |
Structure Therapeu Sp Adr (GPCR) | 0.6 | $1.1M | 24k | 43.89 | |
Inari Medical Ord (NARI) | 0.6 | $1.0M | 25k | 41.24 | |
Moderna (MRNA) | 0.6 | $933k | 14k | 66.83 | |
Cogent Biosciences (COGT) | 0.5 | $912k | 84k | 10.80 | |
Goodrx Hldgs (GDRX) | 0.5 | $805k | 116k | 6.94 | |
Rocket Pharmaceuticals (RCKT) | 0.5 | $801k | 43k | 18.47 | |
Olema Pharmaceuticals (OLMA) | 0.5 | $788k | 66k | 11.94 | |
Uniqure SHS (QURE) | 0.4 | $754k | 153k | 4.93 | |
Illumina (ILMN) | 0.4 | $749k | 5.7k | 130.41 | |
Dex (DXCM) | 0.4 | $717k | 11k | 67.04 | |
Insmed (INSM) | 0.4 | $707k | 9.7k | 73.00 | |
Humana (HUM) | 0.4 | $691k | 2.2k | 316.74 | |
Engene Holdings (ENGN) | 0.4 | $622k | 94k | 6.60 | |
Beigene Sp Adr | 0.3 | $592k | 2.6k | 224.51 | |
Summit Therapeutics (SMMT) | 0.3 | $585k | 27k | 21.90 | |
Roivant Sciences SHS (ROIV) | 0.3 | $521k | 45k | 11.54 | |
Intra Cellular Therapies (ITCI) | 0.3 | $471k | 6.4k | 73.17 | |
Royalty Pharma Shs Class A (RPRX) | 0.3 | $465k | 16k | 28.29 | |
Bridgebio Pharma (BBIO) | 0.2 | $384k | 15k | 25.46 | |
United Therapeutics Corporation (UTHR) | 0.2 | $380k | 1.1k | 358.35 | |
Ionis Pharmaceuticals (IONS) | 0.2 | $378k | 9.4k | 40.06 | |
Tarsus Pharmaceuticals (TARS) | 0.2 | $372k | 11k | 32.89 | |
Medpace Hldgs (MEDP) | 0.2 | $363k | 1.1k | 333.80 | |
Vera Therapeutics Cl A (VERA) | 0.2 | $328k | 7.4k | 44.20 | |
Springworks Therapeutics (SWTX) | 0.2 | $321k | 10k | 32.04 | |
Ascendis Pharma A S Sp Adr (ASND) | 0.2 | $320k | 2.1k | 149.31 | |
Viatris (VTRS) | 0.2 | $298k | 26k | 11.61 | |
Apellis Pharmaceuticals (APLS) | 0.2 | $297k | 10k | 28.84 | |
Crinetics Pharmaceuticals In (CRNX) | 0.2 | $296k | 5.8k | 51.10 | |
Revolution Medicines (RVMD) | 0.2 | $292k | 6.4k | 45.35 | |
Turnstone Biologics Corp (TSBX) | 0.2 | $288k | 518k | 0.56 | |
Exelixis (EXEL) | 0.2 | $286k | 11k | 25.95 | |
Ptc Therapeutics I (PTCT) | 0.2 | $282k | 7.6k | 37.10 | |
Perspective Therapeutics (CATX) | 0.2 | $272k | 20k | 13.35 | |
Novo-nordisk As Adr (NVO) | 0.2 | $262k | 2.2k | 119.07 | |
Jazz Pharma Shs Usd (JAZZ) | 0.1 | $253k | 2.3k | 111.41 | |
Madrigal Pharmaceuticals (MDGL) | 0.1 | $222k | 1.0k | 212.22 | |
Geron Corporation (GERN) | 0.1 | $209k | 46k | 4.54 | |
Iteos Therapeutics (ITOS) | 0.1 | $160k | 16k | 10.21 | |
J P Morgan Exchange Ultra Shrt Etf (JPST) | 0.1 | $127k | 2.5k | 50.74 | |
Adc Therapeutics Sa SHS (ADCT) | 0.1 | $114k | 36k | 3.15 | |
Kyverna Therapeutics (KYTX) | 0.1 | $112k | 23k | 4.89 |